Annual CFI
-$60.76 M
-$56.53 M-1338.08%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual cash flow from investing activities is -$60.76 million, with the most recent change of -$56.53 million (-1338.08%) on December 31, 2023.
- During the last 3 years, TCRX annual CFI has fallen by -$56.52 million (-1333.67%).
- TCRX annual CFI is now -4772.41% below its all-time high of -$1.25 million, reached on December 31, 2019.
Performance
TCRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$82.35 M
-$48.64 M-144.25%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly cash flow from investing activities is -$82.35 million, with the most recent change of -$48.64 million (-144.25%) on September 30, 2024.
- Over the past year, TCRX quarterly CFI has dropped by -$20.94 million (-34.09%).
- TCRX quarterly CFI is now -327.73% below its all-time high of $36.16 million, reached on March 31, 2024.
Performance
TCRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$77.99 M
-$20.94 M-36.70%
September 30, 2024
Summary
- As of February 7, 2025, TCRX TTM cash flow from investing activities is -$77.99 million, with the most recent change of -$20.94 million (-36.70%) on September 30, 2024.
- Over the past year, TCRX TTM CFI has dropped by -$13.94 million (-21.77%).
- TCRX TTM CFI is now -6470.60% below its all-time high of -$1.19 million, reached on March 31, 2020.
Performance
TCRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TCRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1338.1% | -34.1% | -21.8% |
| 3 y3 years | -1333.7% | -34.1% | -21.8% |
| 5 y5 years | -4772.4% | -34.1% | -21.8% |
TCRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1338.1% | at low | -327.7% | at low | -2449.6% | at low |
| 5 y | 5-year | -4772.4% | at low | -327.7% | at low | -6470.6% | at low |
| alltime | all time | -4772.4% | at low | -327.7% | at low | -6470.6% | at low |
TScan Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$82.35 M(+144.3%) | -$77.99 M(+36.7%) |
| Jun 2024 | - | -$33.72 M(-193.2%) | -$57.05 M(+140.1%) |
| Mar 2024 | - | $36.16 M(+1790.4%) | -$23.76 M(-60.9%) |
| Dec 2023 | -$60.76 M(+1338.1%) | $1.91 M(-103.1%) | -$60.76 M(-5.1%) |
| Sep 2023 | - | -$61.41 M(>+9900.0%) | -$64.05 M(+1993.8%) |
| Jun 2023 | - | -$420.00 K(-49.9%) | -$3.06 M(-32.5%) |
| Mar 2023 | - | -$838.00 K(-39.1%) | -$4.53 M(+7.3%) |
| Dec 2022 | -$4.22 M | -$1.38 M(+224.8%) | -$4.22 M(-16.5%) |
| Sep 2022 | - | -$424.00 K(-77.6%) | -$5.06 M(-7.8%) |
| Jun 2022 | - | -$1.89 M(+256.5%) | -$5.49 M(-27.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$531.00 K(-76.0%) | -$7.51 M(-24.4%) |
| Dec 2021 | -$9.94 M(+134.6%) | -$2.21 M(+159.2%) | -$9.94 M(+9.1%) |
| Sep 2021 | - | -$853.00 K(-78.2%) | -$9.12 M(-5.1%) |
| Jun 2021 | - | -$3.92 M(+32.4%) | -$9.61 M(+59.8%) |
| Mar 2021 | - | -$2.96 M(+113.6%) | -$6.01 M(+41.8%) |
| Dec 2020 | -$4.24 M(+239.9%) | - | - |
| Dec 2020 | - | -$1.39 M(+3.1%) | -$4.24 M(+48.5%) |
| Sep 2020 | - | -$1.34 M(+315.8%) | -$2.85 M(+88.9%) |
| Jun 2020 | - | -$323.00 K(-72.8%) | -$1.51 M(+27.2%) |
| Mar 2020 | - | -$1.19 M | -$1.19 M |
| Dec 2019 | -$1.25 M | - | - |
FAQ
- What is TScan Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for TScan Therapeutics?
- What is TScan Therapeutics annual CFI year-on-year change?
- What is TScan Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for TScan Therapeutics?
- What is TScan Therapeutics quarterly CFI year-on-year change?
- What is TScan Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for TScan Therapeutics?
- What is TScan Therapeutics TTM CFI year-on-year change?
What is TScan Therapeutics annual cash flow from investing activities?
The current annual CFI of TCRX is -$60.76 M
What is the all time high annual CFI for TScan Therapeutics?
TScan Therapeutics all-time high annual cash flow from investing activities is -$1.25 M
What is TScan Therapeutics annual CFI year-on-year change?
Over the past year, TCRX annual cash flow from investing activities has changed by -$56.53 M (-1338.08%)
What is TScan Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TCRX is -$82.35 M
What is the all time high quarterly CFI for TScan Therapeutics?
TScan Therapeutics all-time high quarterly cash flow from investing activities is $36.16 M
What is TScan Therapeutics quarterly CFI year-on-year change?
Over the past year, TCRX quarterly cash flow from investing activities has changed by -$20.94 M (-34.09%)
What is TScan Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TCRX is -$77.99 M
What is the all time high TTM CFI for TScan Therapeutics?
TScan Therapeutics all-time high TTM cash flow from investing activities is -$1.19 M
What is TScan Therapeutics TTM CFI year-on-year change?
Over the past year, TCRX TTM cash flow from investing activities has changed by -$13.94 M (-21.77%)